Innovation1 Biotech Inc. (IVBT)

USD 0.0

(0.0%)

Operating Expenses Summary of Innovation1 Biotech Inc.

Innovation1 Biotech Inc.'s latest annual operating expenses in 2023 was 1.21 Million USD , down -76.86% from previous year.
Innovation1 Biotech Inc.'s latest quarterly operating expenses in 2023 FY was 1.21 Million USD , down -76.86% from previous quarter.
Innovation1 Biotech Inc. reported a annual operating expenses of 5.24 Million USD in annual operating expenses 2022, up 2081.49% from previous year.
Innovation1 Biotech Inc. reported a annual operating expenses of 240.65 Thousand USD in annual operating expenses 2021, up 11.88% from previous year.
Innovation1 Biotech Inc. reported a quarterly operating expenses of 203.61 Thousand USD for 2023 Q2, down -20.55% from previous quarter.
Innovation1 Biotech Inc. reported a quarterly operating expenses of 203.61 Thousand USD for 2023 Q3, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Innovation1 Biotech Inc. (2023 - 2015)

Historical Annual Operating Expenses of Innovation1 Biotech Inc. (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	1.21 Million USD	-76.86%
2022	5.24 Million USD	2081.49%
2021	240.65 Thousand USD	11.88%
2020	215.09 Thousand USD	-65.13%
2019	616.77 Thousand USD	65.86%
2018	371.86 Thousand USD	937.28%
2017	35.85 Thousand USD	2.41%
2016	35 Thousand USD	141.05%
2015	14.52 Thousand USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2023 FY	1.21 Million USD	-76.86%
2023 Q2	203.61 Thousand USD	-20.55%
2023 Q3	203.61 Thousand USD	0.0%
2023 Q4	178.67 Thousand USD	-12.25%
2023 Q1	256.28 Thousand USD	-59.24%
2022 Q1	361.07 Thousand USD	360.3%
2022 FY	5.24 Million USD	2081.49%
2022 Q4	628.82 Thousand USD	-60.58%
2022 Q3	1.59 Million USD	-10.49%
2022 Q2	1.78 Million USD	393.63%
2021 FY	240.65 Thousand USD	11.88%
2021 Q3	47.09 Thousand USD	-16.31%
2021 Q2	56.27 Thousand USD	-4.35%
2021 Q1	58.83 Thousand USD	-7.22%
2021 Q4	78.44 Thousand USD	66.55%
2020 Q3	49.32 Thousand USD	2.66%
2020 Q2	48.05 Thousand USD	-11.51%
2020 Q4	63.41 Thousand USD	28.55%
2020 Q1	54.3 Thousand USD	-51.01%
2020 FY	215.09 Thousand USD	-65.13%
2019 Q3	154.59 Thousand USD	-18.07%
2019 Q2	188.67 Thousand USD	15.99%
2019 Q1	162.66 Thousand USD	-25.9%
2019 FY	616.77 Thousand USD	65.86%
2019 Q4	110.84 Thousand USD	-28.3%
2018 Q4	219.5 Thousand USD	1201.64%
2018 Q2	111.67 Thousand USD	368.84%
2018 Q1	23.81 Thousand USD	57.06%
2018 FY	371.86 Thousand USD	937.28%
2018 Q3	16.86 Thousand USD	-84.9%
2017 Q3	3975.00 USD	-15.44%
2017 Q4	15.16 Thousand USD	281.53%
2017 FY	35.85 Thousand USD	2.41%
2017 Q1	12 Thousand USD	71.54%
2017 Q2	4701.00 USD	-60.85%
2016 Q1	7844.00 USD	169.37%
2016 Q4	7000.00 USD	-53.33%
2016 Q3	15 Thousand USD	190.47%
2016 Q2	5164.00 USD	-34.17%
2016 FY	35 Thousand USD	141.05%
2015 FY	14.52 Thousand USD	0.0%
2015 Q2	2034.00 USD	0.0%
2015 Q3	3820.00 USD	87.81%
2015 Q4	2912.00 USD	-23.77%

Peer Operating Expenses Comparison of Innovation1 Biotech Inc.

Name	Operating Expenses	Operating Expenses Difference
America Great Health	661.23 Thousand USD	-83.701%
Gene Biotherapeutics, Inc.	- USD	-Infinity%
Evolutionary Genomics, Inc.	992.8 Thousand USD	-22.349%
Point of Care Nano-Technology, Inc.	73.41 Thousand USD	-1554.528%
Vicapsys Life Sciences, Inc.	1.04 Million USD	-16.018%